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ARTICLE
Annotation of chromatin states in 66 complete
mouse epigenomes during development
Arjan van der Velde 1,2, Kaili Fan 1, Junko Tsuji1, Jill E. Moore 1, Michael J. Purcaro 1, Henry E. Pratt1 &
Zhiping Weng 1✉
The morphologically and functionally distinct cell types of a multicellular organism are
maintained by their unique epigenomes and gene expression programs. Phase III of the
ENCODE Project profiled 66 mouse epigenomes across twelve tissues at daily intervals from
embryonic day 11.5 to birth. Applying the ChromHMM algorithm to these epigenomes, we
annotated eighteen chromatin states with characteristics of promoters, enhancers, tran-
scribed regions, repressed regions, and quiescent regions. Our integrative analyses delineate
the tissue specificity and developmental trajectory of the loci in these chromatin states.
Approximately 0.3% of each epigenome is assigned to a bivalent chromatin state, which
harbors both active marks and the repressive mark H3K27me3. Highly evolutionarily con-
served, these loci are enriched in silencers bound by polycomb repressive complex proteins,
and the transcription start sites of their silenced target genes. This collection of chromatin
state assignments provides a useful resource for studying mammalian development.
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Multicellular organisms maintain myriad cell types alongdistinct lineages to carry out cellular programs requiredfor development and survival. These cell types have the
same genome but different epigenomes, characterized by chro-
matin accessibility, histone modifications, and DNA methylation,
which cooperate with trans-factors to regulate gene expression
and downstream activities. Thus, systematic annotation of epi-
genomes is essential for understanding the genomic functions.
Experimental techniques such as chromatin immunoprecipitation
followed by sequencing (ChIP-seq)1–3, transposase accessible
chromatin with sequencing (ATAC-seq)4, and whole-genome
bisulfite sequencing (WGBS)5 enable genome-wide profiling of
histone marks, chromatin accessibility, and DNA methylation,
respectively. When several epigenetic marks have been profiled
for a given cell type, computational algorithms such as
ChromHMM6, Segway7, and IDEAS8 can integrate the results to
classify genomic loci into distinct chromatin states predictive of
their function.
Coordinated efforts by the ENCODE consortium and the
Roadmap Epigenomics consortium provided tremendous insights
into gene regulation in a diverse array of human cell and tissue
types9,10. The mouseENCODE project furthered understanding of
mouse tissue and cell types in adults and at one developmental
timepoint (embryonic day 14.5; E14.5)11. ENCODE Phase III
generated 66 complete mouse epigenomes across 12 fetal tissues at
four to seven developmental timepoints, each investigated with ten
assays12: ATAC-seq13, WGBS14, and ChIP-seq of eight histone
marks13. The histone marks included histone 3 lysine 4 trimethy-
lation (H3K4me3) and histone 3 lysine 9 acetylation (H3K9ac),
enriched at promoters and present at enhancers1,15–17; H3K27ac,
H3K4me1, and H3K4me2, enriched at enhancers1,15,17,18;
H3K36me3, enriched within bodies of actively transcribed genes19;
H3K27me3, catalyzed by and guiding the polycomb repressive
complexes (PRC) of proteins to repress gene expression20; and
H3K9me3, enriched in heterochromatin to silence repeats and gene
clusters19. All 66 epigenomes were accompanied by transcriptome
sequencing (RNA-seq)21 and DNase-seq, another technique for
measuring chromatin accessibility22 (Fig. 1a and Supplementary
Data 1). This collection represents the most complete epigenetic
data set of fetal mouse tissues, ideal for characterizing the epige-
nomic landscape of mammalian development.
We applied ChromHMM6 to these 66 mouse epigenomes, and
defined 18 chromatin states (Fig. 1b). Most of these recapitulated
the 15 human chromatin states defined by the Roadmap Epige-
nomics Consortium on five-mark human epigenomes10 and the
15 mouse chromatin states defined by the Ren lab using only the
eight histone modifications13. Some of the states in our ten-mark,
18-state model corresponded to refinements of previously defined
enhancer, bivalent, and quiescent states.
We further investigated one chromatin state in detail—TssBiv,
a bivalent state enriched in transcription start sites (TSS) har-
boring both active marks (H3K4me3, H3K4me2, H3K4me1, and
H3K9ac) and the repressive mark H3K27me3. Genes with biva-
lent TSSs were first identified in embryonic stem cells and
thought to be poised for activation or repression in response to
developmental or environmental cues23. Subsequently, bivalent
regions have been extensively studied in developmental and adult
tissue and cell types24–30 (for details, see recent reviews31,32). The
ENCODE epigenomes provide the opportunity to analyze biva-
lent domains across tissues and developmental timepoints sys-
tematically. We find that TssBiv loci are substantially more
evolutionarily conserved than loci in the other 17 chromatin
states. Each fetal tissue harbors ~3000 bivalent genes; many are
transcription factors (TFs) repressed in the given tissue and dif-
ferentially expressed among the others. Comparison with recently
defined silencers bound by the PRC2 proteins33 revealed that
both silencers and the TSSs of their silenced genes are highly
enriched in the bivalent regions. Thus, bivalent regions support
an evolutionarily conserved silencing mechanism for lineage-
specific genes, particularly master TFs controlling tissue devel-
opment. Our comprehensive annotation of chromatin states
provides a resource for studying mammalian development.
Results
Chromatin states are defined using ATAC-seq, WGBS, and the
ChIP-seq data of eight histone marks. The 66 fetal mouse epi-
genomes from the C57BL/6 strain, all complete with ten chromatin
marks, represent a comprehensive collection for chromatin state
assignment (Fig. 1a). We used ChromHMM to learn 18 states
jointly from this data set (Fig. 1b, c). ChromHMM divides the
genome into non-overlapping 200 base-pair (bp) bins, which it
assigns to one of the 18 chromatin states in each biosample. We
named our chromatin states to maximize consistency with earlier
ChromHMM publications6,10,34; two are proximal to active TSSs
(Tss and TssFlnk, on average occupying 1.4% of the mouse gen-
ome); two states associate with actively transcribed genes (Tx and
TxWk, 7.2%); five states are enhancer-related (Enh, EnhLo,
EnhPois, EnhPr, and EnhG; 3.9%); one bivalent state often falls near
inactive TSSs (TssBiv, 0.3%); three states are repressive (ReprPC
and ReprPCWk enriched in H3K27me3, 3.7%; and Het in
H3K9me3, 1.8%); and five states are quiescent (QuiesG, Quies,
Quies2, Quies3, and Quies4; 78.7%). The remaining 3% of the
genome could not be confidently assigned to any one state (denoted
“unassigned”; posterior probability less than 0.5).
State assignments are supported by comparison with gene
expression and epigenomic data available for a subset of
biosamples (Supplementary Data 1). Although both the active-
TSS (Tss) and the bivalent TSS states (TssBiv) are highly enriched
in CpG islands, Tss (along with the TSS-flanking state TssFlnk) is
only enriched in the TSSs of expressed genes (determined using
RNA-seq data in the corresponding biosample). In contrast,
TssBiv is only enriched at TSSs of repressed genes (Fig. 1c). The
transcription-related states (Tx and TxWk) are enriched in exons
and introns of expressed genes but not repressed genes (Fig. 1c).
Enh (high-signal enhancer) is the state most enriched in ChIP-
signal for EP300, a histone acetyltransferase that preferentially
binds active enhancers35,36 (Fig. 1c). The relative enrichment of
the 18 states for ATAC-seq signal is consistent with enrichment
in DNase hypersensitive sites (DHS) determined using DNase-seq
data in the corresponding biosample (Fig. 1c).
Contributions of the chromatin marks to the assignments of
chromatin states. To assess the contribution made by each of the
eight histone marks, ATAC, and DNA methylation, we asked
how accurately the ten-mark model would be able to annotate a
new epigenome missing data for one of the marks. We addressed
this question using the midbrain E13.5 epigenome by removing
the data for each mark individually and computing the Jaccard
similarity index between the chromatin state assignments of all
genomic bins (each 200-bp long, which is the resolution of
ChromHMM) using the data for the remaining nine marks. In
general, when a mark is removed, the states most severely affected
were among those states most enriched in this mark in the ten-
mark model (compare Fig. 1d and the chromatin-mark prob-
abilities in Fig. 1c). However, the converse is not necessarily true,
reflecting the redundancy between the marks. For example, the
removal of H3K27ac affects the low-signal enhancer state
(EnhLo) although the high-signal enhancer (Enh) state is even
more enriched in H3K27ac than EnhLo (Fig. 1c–d). H3K4me3
and H3K9ac, when removed individually, did not have a major
impact on any of the states although promoter states are enriched
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in H3K4me3 and both promoter and enhancer states are enriched
in H3K9ac (Fig. 1c–d), indicating that the information contained
by each of these two marks is already accounted for by the other
nine marks. On the other hand, H3K36me3, H3K27me3, and
H3K9me3 each brings non-redundant information to the ten-
mark model, as all the states enriched in each of these marks were
affected when the mark was removed (Fig. 1c–d).
Chromatin states are conserved between human and mouse.
The Roadmap Epigenomics Consortium previously defined 15
human chromatin states using five histone marks in 127 human
biosamples10. To investigate the conservation of chromatin state
types between human and mouse, we built a 15-state model using
the same set of five histone marks in the 66 mouse fetal bio-
samples (Supplementary Fig. 1a). Visual comparison of the
chromatin states in our five-mark 15-state mouse model and
those in the five-mark 15-state human model by the Roadmap
Epigenomics Consortium revealed that 13 states had similar
emission probabilities. These 13 states, including the promoter,
enhancer, transcribed, repressed, and bivalent states, were enri-
ched in at least one of the five histone marks. The remaining two
human states—the weak transcription state TxWk and the weak
repressed polycomb state ReprPCWk (11.6% and 8.3% of the
human genome)—had low signals for all five marks10. Instead, we
identified in mouse a QuiesG state with low signals for all marks
and a minor state TxWk marked by low levels of H3K36me3 and
H3K27me3 (25.17% and 0.13% of the genome). In summary, our
results indicate that the chromatin states are highly conserved
between human and mouse, and ChromHMM is able to identify
these states reliably.
Addition of histone marks, chromatin accessibility, and DNA
methylation further clarifies enhancer, bivalent, and quiescent
states. We built another 15-state mouse model using all eight
Fig. 1 Overview of the 66 epigenomes and 18 chromatin states during mouse embryogenesis. a Twelve tissues at 4–7 developmental timepoints have
ChIP-seq data for eight histone marks (green boxes), ATAC-seq data, and DNA methylation (DNAme) data, totaling 66 complete epigenomes. Twenty-
one of these epigenomes also have DNase-seq data (green dots). Embryonic stem cells (orange box) have ChIP-seq data for seven histone marks, and are
missing H3K4me2, ATAC-seq, and DNAme. b Eighteen chromatin states are defined by ChromHMM across the 66 complete epigenomes. c Histone-mark
probabilities, genome coverage (averaged over 66 epigenomes, posterior probability > 0.5), and overlapping genomic features including gene expression,
regulatory features (EP300 binding, CTCF binding, and DNase I hypersensitive sites), and distances to the TSSs of expressed and repressed genes are
shown for each chromatin state. The enrichments for the categories are the averaged values across tissues and timepoints. d Jaccard similarities between
the partial epigenomes with each mark omitted and the ten-mark E13.5 midbrain epigenome. e The Dlx1 locus is displayed with chromatin states (color-
coded as in b) in the forebrain and the liver for all seven timepoints. Also shown are the signals of several histone marks (scale: 0–50) that differ between
forebrain and liver (for E11.5, E13.5, E15.5, and P0 only, due to space constraints), along with ATAC and DNA methylation signals. A transgenic mouse
embryo is shown on top of the enhancer region, indicating the forebrain-specific activity of this enhancer. A CpG island that overlaps with the bivalent
region at the TSS of Dlx1 is shown at the bottom of the panel.
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available histone marks (Supplementary Fig. 1a), similar to the
model in another ENCODE3 companion paper13 (see Methods).
As additional marks are incorporated, state assignments differ
predominantly for the enhancer, bivalent, and quiescent states
(Supplementary Fig. 1). The five-mark model specified one
enhancer state (Enh; 3.7% of the mouse genome) with high
H3K4me1 (Supplementary Fig. 1a). Genomic regions in this state
were assigned to five distinct enhancer states in the eight-mark
model reflecting different levels of the additional enhancer marks
(H3K4me2, H3K9ac, and H3K27ac). Among these five states, the
high-signal enhancer state Enh, which showed high levels for all
of four enhancer marks, occupied only 0.2% of the genome
(Supplementary Fig. 1a, d). The Enh state defined by the ten-
mark model further showed high chromatin accessibility (ATAC
signal) and low DNA methylation, occupying 0.64% of the gen-
ome (Supplementary Fig. 1a, d). The ten-mark model defined
three additional enhancer states, with two of them (EnhLo and
EnhPois) being regroupings of the genomic regions assigned to
the enhancer states in the eight-mark model, and other state
(EnhPr) corresponding to a subset of the regions assigned one of
the enhancer states by the eight-mark model, showing high
chromatin accessibility but low levels of enhancer marks (Sup-
plementary Fig. 1d). Thus, the additional marks led to refined
definitions of enhancer states.
One example of a tissue-specific enhancer is located inside the
housekeeping gene Metap1d (methionyl aminopeptidase Type
1D) and 10 kb upstream of the Dlx1 gene, which encodes a brain-
specific homeobox TF. Dlx1 is highly expressed in the forebrain
(~200 transcripts per million or TPM) but not expressed in most
other tissues including the liver. This enhancer region is
annotated as a high-signal Enh in the forebrain, showing high
ATAC and H3K27ac signals and low DNA methylation. It is
annotated as a quiescent gene (QuiesG) in the liver owing to its
low ATAC and histone-mark signals and high DNA methylation
(Fig. 1e). A VISTA enhancer (accession: hs553) overlapping this
region is active in the forebrain and cranial nerve of mouse
embryos37.
The five-mark model annotated three bivalent states with high
levels of the active marks H3K4me1 and H3K4me3, as well as the
repressive mark H3K27me3; however, the eight-mark and ten-
mark models only annotated one bivalent state, which addition-
ally showed high levels of H3K4me2, H3K9ac, and ATAC and
low DNA methylation (Supplementary Fig. 1a). Roughly the same
set of genomic regions were assigned to these bivalent states
across the three models, suggesting that some of the states that
would capture distinctions among bivalent regions are now used
to capture distinctions among other regions enabled by the
additional marks, e.g., additional enhancer states as described
above (Supplementary Fig. 1e).
The five-mark and eight-mark models annotated one quiescent
state (Quies) having very low signals for all available histone
marks. The ten-mark model defined three additional quiescent
states besides Quies, which exhibit low levels of histone marks
and ATAC but varying levels of DNA methylation (Supplemen-
tary Fig. 1a). The quiescent states in the three models cover
roughly the same genomic regions (Supplementary Fig. 1b).
Among the 18 states of the ten-mark model, Quies2 has the
highest percentage of genomic bins without any CpG dinucleo-
tides (50%; Supplementary Fig. 2a). For no-CpG bins, DNA
methylation was labeled as “missing data” (see Methods);
nonetheless, Quies2 bins with one or more CpGs also show low
DNA methylation, whereas the other three quiescent states show
higher DNA methylation levels regardless of CpG count
(Supplementary Fig. 2b–e). In contrast, the Tss state shows low
DNA methylation anticorrelated with CpG count (Supplementary
Fig. 2f), consistent with previous observations for promoters38.
Some regions in the quiescent states may be in low-signal
H3K27me3 and H3K9me3 domains. We define two types of
repressive states: ReprPC and ReprPCWk, the two states highly
enriched in H3K27me3, jointly occupy 3.7% of the mouse gen-
ome, and Het, the state highly enriched in H3K9me3, occupies
1.8% of the mouse genome (Fig. 1c). However, Zaret and col-
leagues reported much larger genomic footprints for H3K27me3
domains (10.6% of the human genome) and H3K9me3 domains
(19.6% of the human genome) in BJ fibroblasts39. Thus, we
directly examined the 15-state five-mark model by the Roadmap
Epigenomics Consortium on a similar human cell line, IMR90
lung fibroblast, which assigned 4.4% and 13.8% of the human
genome to ReprPC and ReprPCWk, overlapping 24.6% and
43.5% of Zaret’s H3K27me3 domains, respectively, and 8.5% of
the genome to Het, occupying 29.8% of Zaret’s H3K9me3
domains. Meanwhile, 17% of Zaret’s H3K27me3 domains and
60% of Zaret’s H3K9me3 domains were in the Quies state
although the ReprPC and ReprPCwk states were the most enri-
ched in H3K27me3 domains and the Het state was the most
enriched in H3K9me3 domains. Our 18-state ten-mark mouse
model defines five quiescent states (Quies, Quies2, Quies3,
Quies4, QuiesG) collectively occupying 80.5% of the mouse
genome. These states show closed chromatin, very low levels of
histone marks, and varying levels of DNA methylation. Except for
Quies2, the other four quiescent states show low levels of
H3K27me3 and H3K9me3 (Fig. 1c), the two repressive histone
marks, and could encompass some of the H3K27me3 and
H3K9me3 domains.
Variation of state assignments across tissues and develop-
mental timepoints. We assessed variability among state assign-
ments across the 66 mouse epigenomes with the Jaccard
similarity index. Enhancer states and the repressive Het state
exhibited the greatest variability among tissues or across time-
points, whereas the quiescent (especially Quies2), promoter, and
transcription states showed the least variability (Fig. 2a). More-
over, all states were more similar across timepoints in the same
tissue than across tissues at the same timepoint (Fig. 2a), con-
sistent with the notion that the epigenome is inherited within cell
lineages. Temporal chromatin state transitions for each tissue
occurred mostly between related states, e.g., among the promoter
states (Tss, TssFlnk, and TssBiv) or among the enhancer states
(Enh, EnhLo, EnhPois, and EnhPr) (Fig. 2b, c).
To investigate whether variations in chromatin states could
recapitulate the developmental trajectory, we applied the UMAP
dimension-reduction technique40 to the 66 epigenomes. H3K27ac
signal within Enh regions (5.4% of the genome) cleanly
segregated the biosamples by tissue (Fig. 2d, left panel), as did
signals for the ten chromatin marks at bivalent regions (TssBiv,
1.2% of the genome; Fig. 2d, right panel). The two organs that
differentiate early, the heart (with a mesoderm origin) and the
liver (endoderm), formed two separate clusters. Tissues with
similar developmental origins were positioned near each other,
with the four brain regions (ectoderm), the lung and the digestive
tract (endoderm), and the limb and facial prominence (with cells
from both endoderm and ectoderm origins) forming three
clusters (Fig. 2d). The kidney (mesoderm) biosamples positioned
near the endoderm biosamples. The liver does not cluster with the
other endoderm organs likely because it differentiates much
earlier, becoming a functional organ of hematopoiesis from E11.5
to E16.541 and undergoing global demethylation during this
process14. In contrast, the lung, stomach, and intestines do not
need to be functionally differentiated until birth. The limb and
facial prominence tissues clustered together, reflecting parallels in
the development of these two organs42,43. Furthermore, within
ARTICLE COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-021-01756-4
4 COMMUNICATIONS BIOLOGY |           (2021) 4:239 | https://doi.org/10.1038/s42003-021-01756-4 | www.nature.com/commsbio
each tissue, the earlier timepoints (open symbols in Fig. 2d) were
segregated from later timepoints (filled symbols). Thus, the
epigenomic landscapes captured by chromatin states Enh and
TssBiv can accurately recapitulate the tissue lineages during fetal
development.
Genome regions transit among TssBiv, Tss, and ReprPC states.
Bivalent promoters in embryonic stem cells are “resolved” to
become monovalent upon differentiation, with activated genes
losing H3K27me3 and repressed genes losing H3K4me344.
Similar results have been reported for cells committed to various
lineages26,27,29. Consistent with earlier results in both embryonic
stem cells and differentiated cell lineages26,27,29,30,44,45, we found
that over developmental time, regions assigned to the bivalent
promoter state (TssBiv), which has both active marks and the
repressive H3K27me3 mark (Fig. 1c), can either lose repressive
H3K27me3 and become active TSSs (Tss) or lose the active marks
and transition into the repressive polycomb (ReprPC) state
(Supplementary Fig. 3a). For example, the promoter of the Dlx1
gene is annotated as Tss in the forebrain, where it is highly
expressed, and TssBiv in the liver, where it is not expressed and
surrounded by ReprPC regions (Fig. 1e).
Roughly 0.3% of any particular epigenome is assigned to the
TssBiv state; cumulatively 1.2% of the genome is assigned to
TssBiv across all tissues and timepoints. TssBiv is less than half as
prevalent as Tss and ReprPC, which constitute 0.8% and 0.8% of
each epigenome and 2.2% and 5.5% of the genome overall,
respectively. Almost all stretches of TssBiv genomic bins are
flanked by ReprPC genomic bins. Among the genomic bins that
are assigned TssBiv in any of the epigenomes, 64.7% are assigned
ReprPC in at least one epigenome and 68.1% are assigned Tss in
at least one epigenome (Supplementary Fig. 3b), indicating that
a particular region is TssBiv in some tissue but becomes
monovalent (Tss or ReprPC) in other tissues. Intriguingly, the
overall fraction of TssBiv genomic bins decreased over the course
of the development in all five tissues with seven timepoints,
although due to the small number of timepoints this was
statistically significant only in the three brain tissues (Supple-
mentary Fig. 3c). This suggests that the resolution of TssBiv
regions into a monovalent state is important for development,
especially in the brain.
Bivalent genes are involved in fundamental biological pro-
cesses. We identified 14,558 bivalent regions, defined as stretches
of TssBiv genomic bins surrounded by repressive chromatin
states in any of the 66 biosamples (see Methods). These bivalent
regions overlapped 14,729 GENCODE-annotated TSSs (Supple-
mentary Data 2), belonging to 6800 genes (Supplementary
Data 3). There were 1077 genes that were bivalent in all 12 tissues
(i.e., having at least one bivalent TSS at one or more timepoints of
Fig. 2 Variations of the chromatin states across tissues and their transitions along the developmental trajectory. a Jaccard similarity between different
timepoints in the same tissue (y axis) versus the similarity between different tissues at the same timepoint (x axis). Error bars indicate the range between
the first and third quartiles. b Transitions between chromatin states along midbrain developmental timepoints. For clarity, only the genomic bins assigned
TSS-related states (Tss, TssFlnk, and TssBiv) at one or more timepoints are included. c Same as b but for genomic bins assigned enhancer-related states
(Enh, EnhLo, EnhPois, and EnhPr) at one or more developmental timepoints. d Visualization of the 66 epigenomes in two dimensions using the UMAP
technique. (Left) UMAP was given the H3K27ac signals in the Enh genomic bins across the 66 epigenomes. There were 735,048 such genomic bins, which
were assigned Enh in one or more epigenomes. (Right) UMAP was given the signals of all 10 marks in the TssBiv genomic bins across the 66 epigenomes.
There were 156,752 such genomic bins, which were assigned TssBiv in one or more epigenomes.
COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-021-01756-4 ARTICLE
COMMUNICATIONS BIOLOGY |           (2021) 4:239 | https://doi.org/10.1038/s42003-021-01756-4 |www.nature.com/commsbio 5
every tissue), and these genes were highly enriched in Gene
Ontology (GO) terms related to embryonic development of
myriad organs and systems, regulation of fundamental cellular
processes, and modulation of cell–cell communications (Supple-
mentary Fig. 4a and Supplementary Data 4a, b).
The liver had 5482 bivalent genes (i.e., having at least one
bivalent TSS at one or more timepoints), 74% more than the
other 11 tissues on average, and 1291 of these 5482 genes were
not bivalent in the other 11 tissues. This is because the liver
genome undergoes global CpG demethylation from E11.5 to
E16.5, precisely coincident with the onset of fetal liver
haematopoiesis, showing large swaths of the genome in partially
methylated domains that are enriched in H3K9me3 and
H3K27me3 but depleted of H3K27ac14. This phenomenon is
likely caused by the failure of mCG maintenance in rapidly
dividing cells during haematopoiesis14. GO analysis on the 1291
liver-only bivalent genes revealed terms that were involved in the
development of a wide variety of organs other than the liver, such
as heart, kidney, smooth muscle, brain, and cytoskeleton
(Supplementary Fig. 4b and Supplementary Data 4c, d). We
observed similar results for bivalent genes specific to other tissues.
Thus, the bivalent genes in each fetal tissue reflect the regulatory
pathways that are unused by the developmental program of that
specific tissue. Our results are consistent with earlier findings on
bivalent genes in other cell and tissue types23,26–30,45,46.
Bivalent genes exhibit repressed transcription. Earlier studies of
bivalent genes revealed that they are poised or repressed for
transcription23,26–30,45,46. We further analyzed the expression of
the 25,215 genes that were expressed (≥1 TPM) in at least one of
the 66 biosamples, among which 6324 were among our list of
bivalent genes (see Methods). We found that the bivalent genes in
a tissue had lower expression levels than non-bivalent genes
according to RNA-seq data in the same tissue. Across the 66
biosamples, the expression levels of bivalent genes were 5.2 ± 1.7
TPM, much lower than the expression levels of non-bivalent
genes (39.8 ± 2.1 TPM; Wilcoxon rank-sum test P value < 2.2 ×
10−16). Furthermore, the genes that were not bivalent in any of
the timepoints of a tissue were expressed 7.79-fold higher (Wil-
coxon rank-sum test P values ≤ 2.2 × 10−16) than the genes that
were bivalent at all timepoints of the tissue (Supplementary
Fig. 5). In a particular tissue, genes that were bivalent at different
timepoints were largely consistent (forebrain in Fig. 3a; all tissues
in Supplementary Fig. 6). For example, 1830 genes were bivalent
at all seven timepoints of the liver; only 439 such genes would be
expected if the timepoints were independent of one another
(P value < 2.2 × 10−16; Binomial test). Genes bivalent at the ear-
liest timepoint but not the latest timepoint were expressed at
significantly lower levels earlier in development; likewise, genes
bivalent at the latest timepoint but not at the earliest timepoint
were expressed at lower levels later in development (midbrain in
Fig. 3b; all tissues in Supplementary Fig. 7). Both of these two sets
of genes were expressed at significantly higher levels than genes
bivalent at all timepoints in the same tissue (Fig. 3b, Supple-
mentary Fig. 7). Overall, the average expression level of a TSS
across the timepoints in a tissue is anticorrelated with the number
of timepoints at which the TSS is in a genomic bin assigned to the
TssBiv chromatin state; in sharp contrast, a positive correlation is
observed between expression and the duration the TSS is in a
genomic bin assigned to the Tss chromatin state (Fig. 3c; Sup-
plementary Fig. 8). Thus, the expression of bivalent genes is
repressed in a tissue- and timepoint-specific manner.
Bivalent genes are highly enriched in tissue-specific TFs. We
compared the 6797 bivalent genes (6324 expressed in at least one
of the 66 biosamples) with a curated list of 552 TFs with known
DNA binding motifs in both mouse and human47, of which 535
were expressed in at least one of the 66 biosamples. A majority of
the 535 TFs (338, 63.2%) were among the 6324 bivalent genes
(Chi-square P value < 2.2 × 10−16), consistent with earlier find-
ings in embryonic stem cells23. Bivalent genes, both TF and non-
TF, were significantly more tissue-specific than non-bivalent
genes (2.47-fold and 1.79-fold higher median tissue specificity
for TFs and non-TFs, respectively, Wilcoxon rank-sum test
P values < 2.2 × 10−16; Fig. 3d).
Consistent with earlier findings in embryonic stem cells48,49,
a majority of the bivalent TSSs in our mouse fetal
biosamples (mean= 62.5% across the 66 biosamples) overlapped
CpG islands; in contrast, only a minority of non-bivalent
TSSs did (mean= 29.8%; Chi-square P values in all 66
biosamples < 2.2 × 10−16). The enrichment holds for both TF
genes (mean= 64.4% for bivalent TSSs vs. 43.5% for non-
bivalent TSSs; P values < 2.2 × 10−16) and non-TF genes (62.3%
vs. 29.5%, P value < 2.2 × 10−16). CpG promoters are known
to be less tissue-specific than non-CpG promoters38, which
seems to conflict with our above finding that bivalent genes
are significantly more tissue-specific than non-bivalent genes
(Fig. 3d). To investigate the apparent contradiction, we separated
bivalent and non-bivalent TSSs into CpG and non-CpG sub-
groups. Indeed, each CpG subgroup is significantly less tissue-
specific than the non-CpG subgroup with the same valency;
however, the bivalent CpG subgroup is significantly more tissue-
specific than the non-bivalent CpG group (Supplementary Fig. 9).
Specifically, bivalent CpG TFs (N= 314) are significantly more
tissue-specific than non-bivalent CpG TFs (N= 162; Wilcoxon
rank-sum test P value < 2.2 × 10−16).
Bivalent enrichment is particularly strong among extremely
tissue-specific TFs. Seventy-five TFs had tissue specificity scores
higher than 6, meaning their expression in their primary tissue is
as high as in all other tissue combined (see Methods); of these, 62
were bivalent. Tissue-specific gene expression (Fig. 4a) and
chromatin state assignments around eight examples TFs
(Fig. 4b–i) reveal distinct modes of gene repression. We highlight
one pair of paralogous TFs (Fig. 4d, e). Gata4 is a bivalent gene
that regulates cardiac development50; it is primarily expressed in
the heart with low expression in the gastrointestinal tract.
Accordingly, its TSS exhibits broad Tss states in the heart, narrow
Tss regions surrounded by TssBiv and ReprPC regions in the
stomach and intestine, and only TssBiv and ReprPC regions in
other tissues (Fig. 4e). Gata4’s paralog Gata1 is a key regulator of
erythrocyte development51 and is predominantly expressed in
the fetal liver, but interestingly it is a non-bivalent gene: its TSS
exhibits a broad Tss domain in the liver and a narrow Tss domain
during early timepoints of the heart, but is labeled Quies in other
tissues (Fig. 4d). Thus, there are two distinct TSS modes for gene
repression: bivalent and quiescent TSSs.
Other bivalent TFs also exhibit tissue-specific chromatin state
patterns. The homeobox-containing TF Dlx1 is required for the
migration of GABAergic neuron progenitor cells from the
subcortical telencephalon to the neocortex52; it is expressed in
the forebrain and facial prominence where its TSS adopts the Tss
state, but is repressed and adopts the TssBiv-ReprPC repressive
states in other tissues (Fig. 1e). Arx is another homeobox-
containing TF with a similar forebrain specificity (Fig. 4b); it is
important for the maturation and migration of GABAergic
interneurons, and its loss-of-function causes lissencephaly
(smooth brain) in humans53. En2 encodes a homeobox TF
expressed at high levels in Purkinje cells functioning as a
transcriptional repressor in neurodevelopment54; it is specifically
expressed in the midbrain and hindbrain with corresponding
tissue-specific chromatin patterns (Fig. 4c). Wilms’ tumor-1
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Fig. 3 Count and expression of bivalent genes along developmental timepoints. a The number of bivalent genes at 1–7 timepoints in the midbrain.
Observed and expected numbers of genes are in red and in gray, respectively. b Median expression levels of three groups of genes: (green) bivalent at the
earliest timepoint but not at the last timepoint, (blue) bivalent at the last timepoint but not at the first timepoint, and (pink) bivalent at all timepoints.
c Distribution of gene expression, with genes grouped by the total number of timepoints at which their TSSs are in the bivalent state TssBiv (left) or in the
active state Tss (right) in the forebrain. The total number of genes in each group is shown below each boxplot in parentheses. For all boxplots, whiskers
show 95% confidence intervals, boxes represent the first and third quartiles, the vertical midline is the median, and outliers are omitted. There is a negative
correlation between expression and the duration of the bivalent state and a positive correlation between expression and the duration of the active state
(P values < 2.2 × 10−16). d Violin plots show the distributions of tissue specificity scores for bivalent and non-bivalent genes that encode transcription
factors (TFs) and non-TFs. Medians are shown in black bars with values indicated. P values are shown for three comparisons as indicated.
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(WT1), which encodes a TF and RNA-binding protein, is
essential for kidney development55. It is predominantly expressed
in the kidney and at lower levels in the heart, stomach, and
intestine; its TSS is in the Tss state in the kidney, exhibits a broad
TssBiv domain in the heart, and is TssBiv-ReprPC in other tissues
(Fig. 4f). The forkhead TF Foxq1 is required for the maturation of
mucin-producing foveolar cells in the developing gastrointestinal
tract56; it is expressed and exhibits the Tss state specifically in
these tissues, and is bivalent in other tissues (Fig. 4g). Evx2 is
required for the morphogenesis of limbs57, consistent with its
expression and chromatin pattern (Fig. 4h). Finally, the aristaless-
like homeobox 1 TF Alx1 has an important role in the
development of craniofacial mesenchyme, the first branchial
arch, and the limb bud; loss-of-function causes severe disruption
of early craniofacial development in humans58. Consistent with
its functions, Alx1 is predominantly expressed in the embryonic
facial prominence and shows the corresponding chromatin
profile (Fig. 4i).
Genomic regions assigned to TssBiv are highly conserved
evolutionarily. TssBiv genomic bins are much more evolutionarily
conserved than bins assigned to the other 17 chromatin states
(Fig. 5a). In each biosample, we calculated the mean PhyloP59 score
in each genomic bin and then averaged these PhyloP scores across
the bins assigned to each chromatin state (see Methods). TssBiv’s
PhyloP score (0.51 averaged over the 66 biosamples) was sub-
stantially higher (Wilcoxon signed-rank test P values < 2.2 × 10−16)
than the transcription-related states Tx (0.41) and EnhG (0.42), the
active-TSS state Tss (0.36), and the high-signal enhancer state Enh
(0.30), which were in turn substantially higher than the remaining
13 states. Quies2 (0.02) was the lowest (Fig. 5a).
Fig. 4 Expression profiles and chromatin states for the transcription factors with the highest tissue specificity scores. a Hierarchical clustering of
expression profiles for the TFs with tissue specificity scores >6, with 75 TFs in total. Rows on the top show the maximal expression level across all
biosamples (intensities of red), bivalency status (brown for 62 bivalent TFs, and yellow for 13 non-bivalent TFs), and tissue specificity score (intensities of
green). b–i Example TFs and the chromatin state assignments near their loci. Among these, Gata1 (d) is a non-bivalent TF and the rest are bivalent TFs: Arx
(b), En2 (c), Gata4 (e), Wt1 (f), Foxq1 (g), Evx2 (h), and Alx1 (i). Each gene name is near the 5′-end of the gene, and CpG islands are indicated as green
boxes beneath each gene. Chromatin states are colored as in Fig. 1b.
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Enhancer-related regions (Enh, EnhLo, EnhPois, and EnhPr)
were most conserved in the four brain tissues (forebrain,
midbrain, hindbrain, and neural tube) and least conserved in
the liver (Fig. 5a), even considering some variations between
timepoints (Fig. 5b, Supplementary Fig. 10). For example, the
average PhyloP score of Enh genomic bins was 0.42 for midbrain,
whereas it was 0.13 for liver (Wilcoxon rank-sum test P value=
5.8 × 10−4 for comparing the seven midbrain timepoints with the
seven liver timepoints). We examined the transposon content in
these Enh genomic bins and found that 40.6% of the Enh
genomic bins in the liver overlapped annotated transposons,
whereas only 14.1–17.5% of those in the four brain tissues did
(Fig. 5c), explaining their substantially different evolutionary
conservation. The prevalence of low-conservation, transposon-
overlapping liver enhancers is due to the global hypomethylation
of the liver genome during hematopoiesis at E11.5 to E16.514.
Fig. 5 Evolutionary conservation of genomic regions by chromatin state. a The PhyloP conservation score (phyloP60way for mm10) for genomic regions
assigned to each chromatin state. Colors correspond to tissues. b PhyloP score for genomic bins assigned to Enh in all 12 tissues. c Percentage of bins
assigned to Enh that overlap with transposons, for all 12 tissues.
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We directly examined the evolutionary conservation of the
TSSs of TFs, stratified by whether they resided in a TssBiv
genomic bin or not (the two bottom-right panels in Supplemen-
tary Fig. 10). The average PhyloP score of the TF TSSs in TssBiv
genomic bins was 0.82, substantially higher than that of the TF
TSSs not in TssBiv genomic bins (0.53, Wilcoxon rank-sum test
P value < 2.2 × 10−16 for comparing the two groups in 66
biosamples). Combined with our aforementioned findings that
TFs are highly enriched in bivalent regions, these results indicate
that TFs with bivalent TSSs have a key role in evolutionarily
conserved pathways driving development.
Genomic regions assigned to TssBiv are enriched in PRC2-
bound silencers and their target TSSs. We used a set of
1800 silencers bound by Polycomb Group 2 proteins (PRC2),
identified using ChIA-PET assays targeting PRC2 component
proteins in mouse embryonic stem cells33, to further annotate our
chromatin states. The PRC2-bound silencers overlapped exten-
sively with our 14,558 bivalent regions (defined as TssBiv geno-
mic bins surrounded by repressive bins; see Methods): 1069 out
of the 1800 silencers overlapped bivalent regions by at least 50%
of the lengths of the silencers, whereas, on average, only
21 silencers overlapped with random regions with matching sizes
as the bivalent regions (Z score= 140; P value < 2.2 × 10−16). In
individual biosamples, centerpoints of most silencers fall within
TssBiv or ReprPC bins (24 ± 4% and 28 ± 6% of silencer centers,
corresponding to 85.7- and 36.4-fold enrichment over the geno-
mic footprints of these states). This is consistent with the
enrichment of these two states in H3K27me3, the histone mark
that PRC2 recognizes specifically.
The PRC2-bound silencers were clustered into four groups
according to their H3K27ac signal profiles across the fetal mouse
tissues33, and these groups are enriched in different chromatin
states. Group 1 silencers (N= 371) had the highest H3K27ac
signals in the fetal mouse tissues33, and their centerpoints fell
within Tss and Enh states in some biosamples, especially in the
brain but not in the liver (Supplementary Fig. 11). Group
2 silencers (N= 126) were depleted in H3K27ac in all fetal mouse
tissues33, and their centers fell in quiescent states in all tissues.
Group 3 and 4 silencers (N= 683 and 620) had intermediate
levels of H3K27ac (higher in Group 3 than in Group 4)33, and
their centers mostly fell in TssBiv and ReprPC states. We
included in these alluvial plots chromatin state assignments in
mouse embryonic stem cells (ES-Bruce4) produced with our 18-
state, ten-mark model; overall, these show similar chromatin state
assignments as in the fetal tissues (see Methods and Supplemen-
tary Fig. 11; note that H3K4me2, ATAC, and WGBS data are not
available for embryonic stem cells). To normalize for the genomic
footprint of each genomic state, we compared genomic bins
assigned to TssBiv (the least abundant state; Fig. 1c) with an equal
number of genomic bins randomly drawn from the other states in
individual biosamples for their overlap with PRC2-bound
silencers. TssBiv showed the highest enrichment for Group 1
and Group 3 silencers and moderate enrichment for Group
4 silencers; ReprPC showed moderate enrichment for all groups
of silencers; Tss showed moderate enrichment for only Group
1 silencers; and no other states showed enrichment (Fig. 6a).
ChIA-PET data further provided target TSSs for each PRC2-
bound silencer33, and these also predominantly fell in TssBiv, Tss,
and ReprPC states. The most active Group 1 silencer had the
highest percentage of active target TSSs of the four subtypes
(Supplementary Fig. 12), a pattern again most prevalent in the
brain and least in the liver (57.9% and 13.4% for forebrain and
liver; Supplementary Fig. 12). After normalizing for the genomic
footprints of the chromatin states, TssBiv showed a strong
enrichment for the target TSSs of all groups of silencers, whereas
Tss and ReprPC showed weak enrichment (Fig. 6b). We further
controlled for the distances between the PRC2-bound silencers
and their target TSSs by randomly drawing non-target TSSs with
the same distance distribution from the PRC2-bound silencers; as
expected, the Tss state is not enriched for this control (it is even
significantly depleted for Groups 2, 3, and 4), but TssBiv and
ReprPC remain significantly enriched (Fig. 6b). Among the 75
tissue-specific TFs (Fig. 4a), 44 of the 62 bivalent TFs but none of
the 13 non-bivalent TFs were targeted by the PRC2-bound
silencers (Fisher’s exact P value= 1.6 × 10−6). Five of the seven
example bivalent TFs (Fig. 4b–i) were targeted by the silencers
(En2, Gata4, Wt1, Foxq1, and Evx2).
Discussion
We defined 18 chromatin states by integrating data on eight
histone marks, chromatin accessibility, and DNA methylation in
66 biosamples across fetal mouse development (Fig. 1). We
recapitulated the human states previously defined by the Road-
map Epigenomics Consortium10 and refined enhancer, bivalent,
and quiescent states. Regions belonging to these states varied
more among tissues at the same developmental timepoint than
across timepoints in the same tissue (Fig. 2a), and the variations
in the Enh and TssBiv regions were specific enough to distinguish
the tissue-of-origin for the 66 biosamples (Fig. 2d). Our chro-
matin state annotation should provide a useful resource for
studying mammalian development.
Because enhancers and promoters have been examined
extensively in previous ChromHMM studies6,10,34, we focused
instead on the TssBiv state. TssBiv has the smallest genomic
footprint among the 18 states (~0.3% of the genome in any
particular biosample), yet is discovered consistently by the five-
mark, eight-mark, and ten-mark models and is the most con-
served evolutionarily of any state (Fig. 5). We define 14,558
bivalent regions upon integration of data in 66 biosamples, of
which roughly half overlap GENCODE-defined TSSs; these
bivalent TSSs are repressed in a tissue-specific manner (Fig. 3)
and are frequently tissue-specific TF genes (Figs. 3, 4). Interest-
ingly, bivalent TF TSSs are significantly more conserved than
their non-bivalent counterparts (Supplementary Fig. 10, bottom
right). Comparison with recent ChIA-PET data33 revealed that
bivalent regions are also enriched in PRC2-bound silencers and
their target TSSs, and conversely, the TSSs of the target genes of
PRC2-bound silencers are highly enriched in the TssBiv state in
individual biosamples (Fig. 6).
Both PRC2-bound silencers and their target TSSs possess the
same epigenetic signature and hence are assigned the same TssBiv
state. This is perhaps not surprising because they are bound by
the PRC, which drives the formation of a three-dimensional
network including low-expression genes with bivalent pro-
moters60. Despite being transcriptionally repressed, bivalent
regions lie within open chromatin regions that associate with the
active compartment61,62. When embryonic stem cells differ-
entiate, bivalent gene activation displaces Polycomb proteins and
disrupts the three-dimensional interactions among Polycomb-
bound regions60,63. Thus, PRC2-bound silencers and their target
TSSs are likely to be in spatial proximity and hence share the
same epigenetic signature. Along this line of reasoning, Enh and
Tss states (Fig. 1c) also share some epigenetic features (open
chromatin, high levels of active histone marks, and low DNA
methylation).
Our systematic analysis of bivalent regions in mouse fetal tis-
sues complements earlier studies on bivalent regions in other cell
types and biological systems. Bivalent regions were first dis-
covered in embryonic stem cells23, where their functions have
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been extensively studied. They have been shown to repress their
associated genes, which were found to be enriched in develop-
mental TFs, and yet allow them to be poised for quick responses
to stimuli23,44. When embryonic stem cells differentiate, these
bivalent genes become monovalent, retaining either the active
marks or the repressive mark, and accordingly being expressed or
repressed19. Subsequent studies reported bivalent domains in
differentiating CD4+ T cells30, the multipotent cranial neural
crest cells29, adult cells in intestinal villi with regenerative
potential26, and terminally differentiated medium spiny neurons
in the striatum27. In each study, disruption of Polycomb group
proteins led to the activation of bivalent genes but not genes
marked by H3K27me3 only26,27, suggesting that bivalency is a
mechanism for persistent gene repression from embryonic stem
cells to terminally differentiated cells.
Our analysis of bivalent genes indicates that they have low
expression levels in the mouse fetal tissues where they are bivalent
and are enriched for developmental TFs under tissue- and
timepoint-specific repression. A repressed gene can be in a
quiescent chromatin state, which corresponds to low levels of all
histone marks and high DNA methylation, such as GATA1
(Fig. 4d). Alternatively, it can be in an H3K9me3-enriched Het
state accompanied by low levels of active histone marks and high
levels of DNA methylation. However, a majority of the bivalent
TSSs in fetal tissues overlap CpG islands (mean= 62.5% across
the 66 biosamples, vs. 29.8% for non-bivalent TSSs). DNA-
hypomethylated CpG islands recruit both Polycomb group and
Trithorax group proteins to lay down H3K27me3 and H3K4me3
marks respectively, and the expression level of the gene reflects
the competition between Polycomb-mediated repression and
Trithorax-mediated activation64–66. As a result, the interplay
between the TssBiv, Tss, and ReprPC chromatin states (Supple-
mentary Fig. 3b) reflects the main mechanism—distinct from
quiescent or Het chromatin states—for silencing genes with CpG-
rich TSSs in a tissue-specific manner throughout fetal develop-
ment and possibly in adulthood.
One limitation of our chromatin state assignments is the het-
erogeneity of cells in a tissue sample. We cannot distinguish a
scenario where a region has low signal across all cell types in a
tissue from one where the region has high signals in a small
Fig. 6 PRC2-bound silencers and their target TSSs are enriched in the TssBiv and ReprPC states. a Percentage of PRC2-bound silencers whose centers
overlap a genomic bin assigned to the TssBiv, Tss, ReprPC, or other chromatin states. Silencers were divided into four groups by Ngan et al.33 according to
H3K27ac signals in mouse fetal tissue biosamples. To normalize for the differential genomic coverage of the chromatin states, matching numbers of
genomic bins were randomly drawn from the other states to match the number of genomic bins in TssBiv in each biosample. States are colored as in Fig. 1b
and the average of the other 15 states is shown as a gray dashed line. b Same as a but for the TSSs targeted by the PRC2-bound silencers defined by
Ngan et al.33. We randomly selected TSSs with the same distance distribution from PRC2-bound silencers as a control (open boxplots).
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subset of cells and no signal in the remaining cells. This limitation
may be of particular relevance for the quiescent states that have
low levels of H3K9me3 and H3K27me3 signals, which could
correspond to heterochromatic regions in a subpopulation
of cells.
In conclusion, we present genome-wide annotations of 18
chromatin states using ten chromatin marks all assayed in twelve
mouse fetal tissues across 4–7 developmental timepoints at daily
intervals from E11.5 to birth. These comprehensive annotations
enabled us to investigate the changes of chromatin profiles across
tissue and timepoints. We analyzed bivalent regions in detail and
found these evolutionarily conserved regions to be highly enri-
ched in master transcriptional factors important for regulating
tissue-specific developmental processes. More broadly, our results
suggest that bivalent regions represent a mechanism for silencing
CpG-rich genes in a tissue- and timepoint-specific manner.
Methods
Experimental data processing for mouse epigenome construction and chro-
matin state definition. We downloaded data sets processed for the mouse genome
(mm10) from the ENCODE Portal12,67 (http://encodeproject.org) that corre-
sponded to eight histone marks (H3K4me1, H3K4me2, H3K4me3, H3K9ac,
H3K27ac, H3K36me3, H3K9me3, H3K27me3), ATAC-seq, and WGBS for each of
66 epigenomes (Supplementary Data 1). All biosamples were from the C57BL/6
mouse strain. For each histone mark, two biological replicates of the ChIP
experiment were performed, and for each epigenome, two replicates of the control
(input) experiment were performed. We ran ChromHMM6 on the 66 epigenomes
at the default 200-bp resolution, assigning each 200-bp genomic bin (13,627,678 of
them in total for the entire mouse genome) to a chromatin state in each biosample.
We used the histone ChIP-seq BAM files and the relevant control files for each data
set. For ATAC-seq data, each BAM file was converted to a signal track as follows.
Reads were extended to their fragment size and counts-per-million were calculated
for all non-overlapping 200-bp genomic bins. Quantile normalization was then
applied across the entire data set and the normalized signal was binarized, using a
threshold of 0.5. For WGBS data, BED files were downloaded from the ENCODE
portal (Supplementary Data 1), These files contain, among other values, the percent
methylation at each CpG dinucleotide in the genome (ranging from 1–100). For
each set of two replicates, these values were averaged in 200-bp genomic bins to
obtain the mean percent methylation of CpGs in each window. The 200-bp bins
were subsequently binarized based on a 50% methylation threshold. Bins that did
not contain any CpGs were marked as missing data, as specified by the
ChromHMM binarized data format.
We defined 18 chromatin states using ChromHMM6 using the processed data
described above on the 10 marks. We used the genomic bins with posterior
probability >0.5 for the downstream analysis; these bins composed 97.1% (±0.53%)
of the genome across the tissue samples.
For comparison, we also made two sets of 15-chromatin-state assignments
using a subset of the data: a five-mark, 15-state model using five histone marks
(H3K4me1, H3K4me3, H3K36me3, H3K9me3, H3K27me3), and an eight-mark,
15-state model using all eight histone marks. The eight-mark, 15-state model is
similar to the ChromHMM model recently published by Gorkin et al.13, with the
following correspondence of states between our model and those of Gorkin et al.:
Tss: Active Promoter (Pr-A, State 1)
TssFlnk1: Strong Enhancer, TSS proximal (En-Sp, state 6)
TssFlnk2: Weak/inactive Promoter (Pr-W, state 2)
Tx: Strong Transcription (Tr-S, state 10)
EnhG: Initiation Transcription (Tr-I, state 12)
Enh: Strong Enhancer, TSS-distal (En-Sd, state 5)
EnhLo1: N/A
EnhLo2: Weak Enhancer, TSS-distal (En-W, state 7)
EnhPois1: Poised Enhancer, TSS proximal (En-Pp, state 9)
EnhPois2: Poised Enhancer, TSS-distal (En-Pd, state 8)
TssBiv: Bivalent Promoter (Pr-B, state 3)
ReprPC: Polycomb-associated heterochromatin (Hc-P, state 13)
QuiesG: Permissive Transcription (Tr-P, state 11)
Quies: No signal (Ns, State 15)
Het: H3K9me3-associated heterochromatin (Hc-H, state 14)
N/A: Flanking Promoter (Pr-F, state 4)
Enrichment of chromatin states in other annotations (Fig. 1c). We assessed the
chromatin state assignments in each of the 66 epigenomes for their enrichments in
three types of annotations (Fig. 1c, the right panel titled Enrichment): (1) for CpG
islands, we downloaded cpgIslandExtUnmasked.txt from the UCSC Genome
Browser; (2) we used GENCODE version M4 for gene-related annotations (TSS,
transcription end sites or TES, gene, exon, and intron); and (3) we used epigenetic
annotations (EP300 and CTCF ChIP-seq peaks and DHS).
For every chromatin state, we computed its enrichment for each annotation,
defined as the observed joint probability (P) of a chromatin state and an annotation
occurring together over the expected joint probability (i.e., assuming the state and
the annotation occur independently):
Enrichment ¼ Pðchromatin statei; annotationjÞ=½Pðchromatin stateiÞ ´ PðannotationjÞ
For visualization (the right panel of Fig. 1c titled Enrichment), the enrichments
were scaled between 0 and 1:
Enrichmentscaled ¼ Enrichment  Enrichmentminð Þ= Enrichmentmax  Enrichmentminð Þ
We further integrated the RNA-seq data (Supplementary Data 1) processed
with the ENCODE uniform processing pipeline to compute the enrichment of the
chromatin states is expressed or repressed genes for each of the 66 epigenomes12.
For plotting the enrichment panels in Fig. 1c, we clustered genes into either
expressed or repressed groups in each biosample based on an expression level
cutoff determined using a two-component Gaussian mixture model. The
expression levels (in TPM) for the two replicates of each biosample were averaged.
We calculated the enrichment of the chromatin states in EP300 and CTCF
ChIP-seq peaks and DHS (the right-most panel in Fig. 1c) for those epigenomes
that had the EP300 and CTCF ChIP-seq or DNase-seq data available in the
corresponding tissues and timepoints (Supplementary Data 1). For the EP300
ChIP-seq data, the BAM files from two biological replicates were pooled, and peaks
were called using MACS268 with the q-value cutoff of 0.01. For the CTCF ChIP-seq
data, the optimal IDR thresholded peaks69 defined by the ENCODE uniform ChIP-
seq pipeline were used12. For the DNase-seq data, the hotspots defined by the
ENCODE uniform DNase-seq processing pipeline were used12.
Partial epigenome simulation and construction (Fig. 1d). To assess the relia-
bility of chromatin state assignments on epigenomes that lacked the data for one of
the ten chromatin marks, for each biosample we simulated ten partial epigenomes,
starting with the ten-mark epigenome and omitting the data for each mark indi-
vidually. We applied the ten-mark 18-state ChromHMM model to the available
data on the remaining nine marks and compared the resulting chromatin states
assignments with the chromatin state assignments of the ten-mark epigenome by
computing the Jaccard similarity between all genomic bins (Fig. 1d). The chro-
matin states with Jaccard similarity <0.5 were labeled as misassigned in the
missing-one-mark epigenomes.
For the comparison with PRC2-bound silencers in embryonic stem cells, we
also performed chromatin state assignment on embryonic stem cells, with data on
seven histone marks (Supplementary Data 1), missing H3K4me2, ATAC, and DNA
methylation data. We simulated the effect of missing three marks using midbrain
and forebrain samples and concluded that they did not have a major impact on the
assignment of the TssBiv state. The chromatin state assignments of the seven-mark
epigenomes were used to define bivalent genes in mouse embryonic stem cells and
compared with the bivalent genes in mouse fetal tissues defined using the
chromatin state assignments of the ten-mark epigenomes (see below).
Chromatin state variations across tissues and timepoints (Fig. 2a). We
computed Jaccard similarity between a pair of epigenomes by comparing the
chromatin states at the corresponding genomic bins between the two epigenomes.
UMAP analysis of the epigenomes (Fig. 2d). We performed two-dimensional
visualization of the 66 epigenomes using UMAP40 analysis on two sets of 200-bp
genomic bins: those assigned to the Enh state or the TssBiv state in one or more
biosamples. For the Enh genomic bins, UMAP was provided with the H3K27ac
signal levels across the 66 biosamples and the following parameters were used:
n_neighbors = 7, min_dist = 0.5, seed = 11. For the TssBiv genomic bins, UMAP
was provided with the signal levels of all ten marks across the 66 biosamples and
the following parameters were used: n_neighbors = 10, min_dist= 0.04, seed = 12.
Identification of bivalent TSSs and bivalent genes (Figs. 3, 4, Supplementary
Figs. 4–8). We developed a method to identify bivalent TSSs and bivalent genes by
their chromatin states in each epigenome, described as follows. We first converted
each epigenome to a character string using an 18-letter alphabet (one symbol for
each state). Regular expressions were then used to extract punctate (median length
1800 bp) bivalent domains (stretches of contiguous genomic bins) in each epi-
genome, defined as bivalent chromatin states flanked by quiescent or hetero-
chromatin states (ReprPC, ReprPCWk, Quies, Quies2, Quies3, Quies4, or QuiesG
state). We used the union (14,558 regions across all tissue timepoints, median 3514
per tissue timepoint, neighboring regions were not merged) of the detected
genomic regions matching our regular expression for downstream analyses. The
14,558 regions detected in the 66 biosamples collectively overlapped 14,729
GENCODE-annotated TSSs; we denote these bivalent TSSs. We further define a
bivalent gene as having at least one bivalent TSS, yielding 6797 genes that are
bivalent in any of the 12 tissues.
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We detected on average ~3400 bivalent genes per tissue, defined as genes that
are bivalent in any of the timepoints in the tissue. We performed Gene Ontology
(GO) analysis on bivalent genes using the PANTHER tool70. The genes used in the
GO analysis, of which the results are listed in Supplementary Data 4 were obtained
as follows: TSSs extracted from the M4 GENCODE annotations were intersected
with the bivalent regions detected in each tissue. For each tissue, genes for which
one or more TSSs intersected were retained. Then, the 1077 genes that were found
to have TSSs overlapping bivalent regions in all tissues were used as input for the
GO analysis (Supplementary Data 4a, b). Another set of 1291 genes was obtained
using the same process, except that these genes had TSSs in bivalent regions only in
liver samples and not in any other 11 tissues (Supplementary Data 4c, d). Gene IDs
were translated into gene names prior to submission to PANTHER. For six gene
IDs, no matching gene name was found, leaving 1074 and 1288 genes in the “all
tissues” and the “liver-only” gene sets for submission. PANTHER was run on the
GO “Biological Process” ontology, using Fisher’s exact test and FDR for P value
calculations.
We computed the expected number of genes in a tissue that would be bivalent
at all seven timepoints if the timepoints were to be independent of one another
(Fig. 3a, Supplementary Fig. 6). Using the liver as an example, we computed the
product of the frequencies of bivalent genes in each timepoint in the liver (0.64,
0.83, 0.78, 0.68, 0.80, 0.73, and 0.52 for E11.5, E12.5,… P0, respectively), then
multiplied this product by the total number of genes bivalent in the liver at one or
more timepoints (N= 5176). For the calculation of the frequency at each
timepoint, we also used the total number of genes bivalent in the liver at one or
more timepoints (N= 5176) as the denominator.
Gene annotations and identification of TFs (Fig. 3d, Fig. 4, Supplementary
Data 2–4). GENCODE M4 gene annotations were used to identify genes and TSSs.
To avoid double-counting TSSs, coinciding TSSs were merged. To identify TFs, we
used the list of TFs and their homologs in mouse and human47. Ensembl IDs were
obtained by mapping gene names to the GENCODE M4 annotations71. In all, 552
TFs matched IDs in the GENCODE M4 mouse annotations.
Evolutionary analysis (Fig. 5a–b, Supplementary Fig. 10). We averaged the
mouse 60-way phyloP59 score across the genomic positions in each 200-bp
genomic bin. We then average this per-bin score for all the genomic bins assigned
to a particular chromatin state in each biosample to obtain the average PhyloP
score per state per biosample (Supplementary Fig. 10, first 18 panels). For each
tissue (Fig. 5a), the PhyloP scores from the biosamples at different timepoints were
further averaged. For the TF TSSs (Supplementary Fig. 10, the two bottom-right
panels), we used the PhyloP score for genomic bins where each TF TSS resided in,
stratified by whether that bin was assigned to the TssBiv state or not.
Overlap of Enh regions with annotated transposons (Fig. 5c). We used
transposon annotations in the mouse genome from Repbase72 to analyze the Enh
state across different tissues (Fig. 5c). We overlapped the genomic bins assigned to
the Enh state in each biosample with annotated transposons, requiring at least one-
bp overlap. The percentage of all genomic bins that overlapped transposons was
used as control (gray dashed line in Fig. 5c).
Analysis of PRC2-bound silencers (Fig. 6, Supplementary Figs. 11, 12). We
used the 18,000 PRC2-bound silencers classified into four groups based on their
H3K27ac signal in mouse fetal tissues33. We overlapped the PRC2-bound silencers
with our 14,558 bivalent regions, requiring at least half of the length of a silencer
length to overlap. We randomly selected genomic regions with the same lengths as
the bivalent regions to act as controls. Furthermore, we assigned each silencer to a
chromatin state in a particular biosample according to which chromatin state the
center of the silencer falls in.
We included embryonic stem cells in this analysis (ES-Bruce4). These cells were
derived from C57BL/6, the same strain of mice from which the tissues were
harvested. We only had data on seven histone marks on embryonic stem cells
(Supplementary Data 1), and simulation of this partial epigenome (see above
Methods) showed no major impact on the assignment of the TssBiv state and the
resulting bivalent genes. Simulating using midbrain and forebrain samples, we
found that most bivalent genes were identified using the partial epigenome. For
example, among the 2250 bivalent genes in the midbrain E11.5 sample, 2014
(89.5%) were identified using the partial epigenome.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
All experimental data used in this paper can be accessed at the encode Portal (http://
www.encodeproject.org/), using the accession IDs listed in Supplementary Data 1.
The chromatin state assignments for both the eight-mark, 15-state model and the
10-mark, 18-state model are also accessible at the ENCODE Portal (https://www.
encodeproject.org/search/?searchTerm=ChromHMM+Zhiping+Weng). State
annotations with posterior probabilities for all 200 bp genomic bins can be found at
https://doi.org/10.6084/m9.figshare.1327170573. Per-bin PhyloP scores and state
durations are available at https://doi.org/10.6084/m9.figshare.1327168474.
Epigenetic signals of Enh states and TssBiv states for UMAP analysis are available at
https://doi.org/10.6084/m9.figshare.1327171775.
We made a track hub (https://publications.wenglab.org/mouse_epigenomes/
trackhub/hub_0.txt) for the UCSC genome browser76 to visualize all the data and
annotations used in this study listed below. The trackhub can be accessed via a
UCSC session: https://genome.ucsc.edu/s/zlab/mouse_epigenomes.
1. Ten-mark, 18-state chromatin state assignments (in dense mode)
BigWig experimental data complete for 66 biosamples (in hide mode):




e. DNase when available
f. EP300 ChIP-seq when available
g. CTCF ChIP-seq when available
2. ES-Bruce4 chromatin state assignments (in dense mode)
BigWig experimental data for ES-Bruce4 (in hide mode)




3. Turn on the GENCODE gene annotation (in pack mode)
4. Turn on the CpG island track from UCSC (in dense mode)
5. Bivalent regions (in dense mode)
6. PRC-bound silencers and their target TSSs in two tracks (in dense mode)
7. Turn on the PhyloP conservation track (in full mode)
8. Turn on VISTA enhancer track hub (in hide mode)
9. Mouse cCREs defined by the ENCODE consortium12 (in hide mode)
Code availability
The code used to extract genomic regions based on regular expression can be found at
https://doi.org/10.5281/zenodo.444838777.
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